Edition:
India

Helius Medical Technologies Inc (HSM.TO)

HSM.TO on Toronto Stock Exchange

2.87CAD
10:46pm IST
Change (% chg)

$0.07 (+2.50%)
Prev Close
$2.80
Open
$2.80
Day's High
$2.90
Day's Low
$2.80
Volume
10,725
Avg. Vol
172,784
52-wk High
$5.09
52-wk Low
$1.72

Latest Key Developments (Source: Significant Developments)

Helius Medical Technologies provides clarification on clinical trial results
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA.  Full Article

Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Helius Medical Technologies Inc :Helius Medical Technologies announces positive results from its registrational clinical trial for traumatic brain injury (TBI).  Full Article

Helius Medical Technologies, Inc announces pricing of unit offering
Thursday, 24 Mar 2016 

Helius Medical Technologies, Inc:Says Co at price of C$1.00 per Unit for gross proceeds of a minimum of C$8 million and up to a maximum of C$20 million.Says each Unit is priced at C$1.00 and consists of one Class A common share in the capital of the Company.Closing of the Offering is expected to occur on or about April 5, 2016, or in any event, no later than June 17, 2016.  Full Article

BRIEF-Helius Medical Technologies provides clarification on clinical trial results

* Helius Medical Technologies provides clarification on clinical trial results and confirms intention to include traumatic brain injury (TBI) registrational and long-term treatment trial data to support application for clearance by the FDA Source text for Eikon: Further company coverage:

No consensus analysis data available.